These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10694825)

  • 1. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
    Qu Z; Huard J
    Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene complementation using myoblast transfer into fetal muscle.
    Sopper MM; Hauschka SD; Hoffman E; Ontell M
    Gene Ther; 1994 Mar; 1(2):108-13. PubMed ID: 7584065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy].
    Luo L; Zhou HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):101-5. PubMed ID: 21355312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise improves the success of myoblast transplantation in mdx mice.
    Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
    Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
    Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
    Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of treating Duchenne muscular dystrophy with myoblast transplantation].
    Liu L; Zhou H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Oct; 23(10):1224-8. PubMed ID: 19957845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice.
    Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C
    Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology and the future of myoblast transfer therapy.
    Smythe GM; Hodgetts SI; Grounds MD
    Mol Ther; 2000 Apr; 1(4):304-13. PubMed ID: 10933948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected.
    Pellegrini KL; Beilharz MW
    Transplantation; 2011 Mar; 91(5):522-6. PubMed ID: 21192317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
    Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
    J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of MyoD increases donor myoblast migration into host muscle.
    Smythe GM; Grounds MD
    Exp Cell Res; 2001 Jul; 267(2):267-74. PubMed ID: 11426945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell therapy for Duchenne muscular dystrophy].
    Zhou C; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):659-61. PubMed ID: 17160947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
    Mueller GM; O'Day T; Watchko JF; Ontell M
    Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
    Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
    Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
    Brussee V; Merly F; Tardif F; Tremblay JP
    Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.